Sjogren's syndrome Clinical Trials

A listing of Sjogren's syndrome medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 111 clinical trials
Fish Oil (Omega 3 ) in Sjogren's Syndrome

Sjögren's syndrome (pSS) is an autoimmune disorder affecting mainly the exocrine glands.this lead to dryness of the main mucosal surface ,such as the mouth ,eye,skin nose,pharynx,larynx and

rheumatism
cancer
  • 0 views
  • 18 Dec, 2021
  • 1 location
Levocarnitine for Dry Eye in Sjogren's Syndrome

This study evaluates the effectiveness of levocarnitine in the treatment of dry eye in adults with Sjogren's syndrome. This will be a crossover study design with all participants receiving both

  • 0 views
  • 05 Jan, 2022
  • 1 location
CEQUA for Sjogren's Syndrome Dry Eye

The primary objective of this study is to show that CEQUA (cyclosporine 0.09% ophthalmic solution) improves symptoms of dry eye disease in a population of patients with Sjogren's Syndrome

  • 0 views
  • 19 Sep, 2021
  • 2 locations
Evaluation of Tangible Boost for Patients With Stevens Johnson Syndrome Sjogren's Syndrome and Graft Vs Host Disease

The goal of this research is to determine if the Tangible Boost system adequately replenishes the Hydra-PEG coating on the surface of a rigid contact lens. Hydra-PEG is a coating for soft and rigid contact lens, primarily composed of polyethylene glycol-based hydrogel, which is covalently bound to the surface of …

  • 0 views
  • 08 Apr, 2021
  • 1 location
Safety of Tofacitinib an Oral Janus Kinase Inhibitor in Primary Sjogren's Syndrome

Background An autoimmune disease is one in which the immune system attacks a person s own body. Sjogren's syndrome (SS) is an autoimmune disease. It often involves

glucocorticoids
autoimmune disease
tofacitinib
chloroquine
hydroxychloroquine
  • 0 views
  • 11 Nov, 2021
  • 1 location
Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder

treatment for overactive bladder syndrome. However, theoretically, undesirable effect of the anti-muscarinic agent such as dry mouth and constipation would make it less suitable for Sjogren syndrome patient

  • 0 views
  • 20 Aug, 2021
  • 1 location
Involvement of Immune Cells Derived From the Intestine in Sjogren's Syndrome

The study aims at defining the role of immune cells derived from the intestine in the pathogenesis of Sjogren's disease. This research might open new therapeutic approaches for the treatment of

autoimmune disease
  • 10 views
  • 26 Jan, 2021
  • 1 location
A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren's Syndrome

A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren's Syndrome

sjogren's syndrome
  • 0 views
  • 28 Oct, 2021
  • 1 location
Efficacy Safety and Immunological Evaluation of Tofacitinib in the Treatment of Primary Sjogren's Syndrome

This study aims to explore the clinical and immunological efficacy of tofacitinib on primary Sjgren's Syndrome

  • 0 views
  • 21 Nov, 2021
  • 1 location
A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD)

This study is a basket trial designed to establish safety, tolerability and efficacy of MHV370 in Sjögren's Syndrome (SjS) and Mixed Connective Tissue Disease (MCTD).

  • 0 views
  • 13 Jan, 2022
  • 5 locations